Mobile

Single blind, randomized, crossover, repeated dose, pharmacokinetic and pharmacodynamic interaction study of CHF 4226 HFA and Extra-fine BUD HFA in asthmatic patients

Update Il y a 4 ans
Reference: EUCTR2006-002094-46

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

- To compare the systemic exposure of the free combination of CHF 4226 HFA and extra-fine BUD HFA pMDI administered once daily for 4 consecutive weeks in comparison with CHF 4226 HFA and extra-fine BUD HFA administered as single agent.

Inclusion criteria

  • Asthmatics patients

Links